QPRT
QPRT (quinolinate phosphoribosyltransferase, also known as QPRTase) is an enzyme involved in the catabolism of quinolinic acid. It sits in the tryptophan-nicotinamide adenine dinucleotide pathway and is classed among the phosphoribosyltransferases. Browse Assay Genie's current range of QPRT research reagents below, or read on for the biology behind the target.
QPRT is a key enzyme in the catabolism of quinolinate (quinolinic acid, QA), an intermediate in the tryptophan-nicotinamide adenine dinucleotide pathway. UniProt describes its function as involvement in the catabolism of quinolinic acid, and its recommended protein name is nicotinate-nucleotide pyrophosphorylase [carboxylating], assigned EC 2.4.2.19.
Quinolinate is of particular interest to neuroscientists because it acts as a most potent endogenous excitotoxin to neurons. According to the NCBI Gene summary, elevated quinolinate levels in the brain have been linked to the pathogenesis of neurodegenerative disorders such as epilepsy, Alzheimer's disease and Huntington's disease. As the enzyme that handles quinolinate breakdown, QPRT is therefore studied in the context of tryptophan metabolism and neuronal health.
The QPRT gene belongs to the HGNC gene group of phosphoribosyltransferases, and the protein belongs to the NadC/ModD family. Alternative splicing of the gene results in multiple transcript variants. Mouse and rat orthologs, both named Qprt, are recognised, which allows the pathway to be examined in common model organisms. Subcellular location is not annotated in UniProt.
QPRT acts on quinolinate, an intermediate in the tryptophan-nicotinamide adenine dinucleotide pathway, making it a focal enzyme for studying this metabolic route.
Raised brain quinolinate has been linked to epilepsy, Alzheimer's disease and Huntington's disease, so QPRT is relevant to work on these disorders.
Quinolinate is a potent endogenous excitotoxin to neurons, and QPRT is a key enzyme in its catabolism.
As a phosphoribosyltransferase whose gene yields multiple transcript variants through alternative splicing, QPRT supports studies of enzyme regulation and expression.
QPRT is a key enzyme in the catabolism of quinolinate, also called quinolinic acid, an intermediate in the tryptophan-nicotinamide adenine dinucleotide pathway. It is classified as nicotinate-nucleotide pyrophosphorylase [carboxylating], EC 2.4.2.19, and belongs to the NadC/ModD family.
The HGNC full name is quinolinate phosphoribosyltransferase, and the alias QPRTase is also used. UniProt lists the protein as nicotinate-nucleotide pyrophosphorylase [carboxylating]. The NCBI Gene summary notes that alternative splicing produces multiple transcript variants of the gene.
Quinolinate, the QPRT substrate, is a potent neuronal excitotoxin, and elevated brain levels have been linked to epilepsy, Alzheimer's disease and Huntington's disease. Orthologs named Qprt exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other tryptophan-metabolism and NAD pathway enzymes and neurodegeneration-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15274; product specifications from Assay Genie datasheets.